
Envamine M 25mg/2.5mg Tablet SR
Marketer
Shinto Organics (P) Limited
Salt Composition
Metoprolol Succinate (25mg) + Ramipril (2.5mg)
Overview Envamine M 25mg/2.5mg Tablet SR
Hypertensive patients benefit from Amlodipine/Valsartan 25mg/2.5mg Extended-Release tablets (a similar medication) to manage elevated blood pressure, thus mitigating the risk of stroke and heart attack. Early intervention significantly improves post-heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as prescribed by your physician. Continued use is crucial, even if feeling well, as hypertension often presents asymptomatically. Discontinuation may worsen the condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, complement medication effectiveness. Closely follow your doctor's instructions. Potential side effects include nausea, dry cough, headache, fatigue, hypotension, and hyperkalemia. Potassium-rich foods and supplements should be avoided. Dizziness may occur; avoid driving or sudden movements. Regular monitoring of blood pressure, glucose, renal function, urea, and electrolyte levels may be necessary. Inform your doctor of any pre-existing liver or kidney disease, or pregnancy/breastfeeding status before commencing treatment. Always disclose all current medications, particularly those for hypertension or cardiac conditions.
Primary Ingredients of Envamine M 25mg/2.5mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Envamine M 25mg/2.5mg Tablet SR
Elevated blood pressure
Major Benefits of Envamine M 25mg/2.5mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Envamine M 25mg/2.5mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
Common Side effects of Envamine M 25mg/2.5mg Tablet SR:
- Nausea
- Taste change
- Vomiting
- Diarrhea
- Constipation
- Cough
- Dizziness
- Weakness
- Headache
- Cold extremities
- Slow heart rate
- Numbness of extremity
- Increased potassium level in blood
- Decreased blood pressure
How to use Envamine M 25mg/2.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Envamine M 25mg/2.5mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Envamine M 25mg/2.5mg Tablet SR works:
Envamine M SR tablets (25mg Metoprolol/2.5mg Ramipril) combine two blood pressure-lowering agents. Metoprolol, a beta-blocker, reduces heart rate and improves its pumping efficiency. Ramipril, an ACE inhibitor, lessens cardiac strain and promotes smoother blood flow by relaxing blood vessels.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Envamine M 25mg/2.5mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Envamine M tablets (25mg/2.5mg) are contraindicated during pregnancy due to established fetal risks. In exceptional life-threatening circumstances, a physician may prescribe this medication if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Envamine M tablets (25mg/2.5mg) are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Envamine M 25mg/2.5mg sustained-release tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Envamine M 25mg/2.5mg Extended-Release tablets. Dosage modification of Envamine M 25mg/2.5mg Extended-Release tablets may be necessary. Physician consultation is advised. Routine blood pressure checks are recommended to guide dosage adjustments.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Envamine M 25mg/2.5mg sustained-release tablets. Dosage modification of Envamine M 25mg/2.5mg sustained-release tablets may be necessary. Physician consultation is recommended. Report any symptoms or signs suggestive of jaundice to your physician during treatment.
What if you forget to take Envamine M 25mg/2.5mg Tablet SR :
Should you forget to take your Envamine M 25mg/2.5mg SR Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Envamine M 25mg/2.5mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
